Hewei Li

2.2k citations
36 papers · 1.7k indexed · 1 hit paper · h-index 14

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
  • Genetics top 10%

Papers in

Hewei Li

32 papers receiving 1.7k citations

Hit Papers

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma 2017 · 874 citations
8742017202620202023250500750

Peers

Hewei Li
Comparison fields: 5 of 104
  • Oncology 1.1k
  • Genetics 156
  • Immunology 280
  • Pulmonary and Respiratory Medicine 337
  • Complementary and alternative medicine 58
Replace Oluwaseun Adebayo Bamodu with:
Oluwaseun Adebayo Bamodu Taiwan
Masanobu Tsubaki Japan
Xuan Zhao China
Yanqing Gong China
Liang-Shun Wang Taiwan
Jianlin Qiao China
Mitsuteru Kitade Japan
Shuangshuang Zeng China
Weikun Qian China
Hewei Li relative to Oluwaseun Adebayo Bamodu Taiwan Oluwaseun Adebayo Bamodu's profile →
Citations per field
00.5×2.8×
Oluwaseun Adebayo Bamodu · 1×
Citations per year

Countries citing papers authored by Hewei Li

Since Specialization
Citations

This map shows the geographic impact of Hewei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hewei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hewei Li more than expected).

Fields of papers citing papers by Hewei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hewei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hewei Li. The network helps show where Hewei Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hewei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hewei Li Line = papers co-authored together Hewei Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20243
3 20230
4 20233
5 20232
6 202214
7 202213
8 20214
9 201711
10 201626
11 201452
12 201416
13 201254
14 201226
15 201236
16 201212
17
AIDS molecular epidemiological survey in Laibin
20111
18 20102
19
Quantitative molecular analysis of MCM6 and MCM7 and their association with HPV E6 and E7 mRNA expression, viral load and physical status in invasive cervical carcinoma
20060
20 199948

About Hewei Li

Hewei Li is a scholar working on Applied Microbiology and Biotechnology, Pharmacology, Oncology, Toxicology and Geriatrics and Gerontology, having authored 36 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (4 papers), Cancer-related molecular mechanisms research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Virus-based gene therapy research (2 papers), RNA Interference and Gene Delivery (2 papers), MicroRNA in disease regulation (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Oncology (1.1k citations), Genetics (156 citations), Immunology (280 citations), Pulmonary and Respiratory Medicine (337 citations) and Complementary and alternative medicine (58 citations). Hewei Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include F. Stephen Hodi, Jeffrey S. Weber, James Larkin, Ian M. Waxman, Caroline Robert, Joel Jiang, Dirk Schadendorf, Georgina V. Long, Jedd D. Wolchok and Mario Sznol. Their work appears in journals such as Alzheimer s & Dementia, Frontiers in Plant Science, Scientia Horticulturae, Journal of Orthopaedic Surgery and Research and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026